TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04848467

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.
“The study cannot be conducted.”

The sponsor’s own words in the registry.

Life of this trial

202120222023Registered2021-04-16Withdrawn (as of)2021-08-11Planned start2021-10-01 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 3
Sponsor
Bayer
Sponsor type
Industry
Conditions
SARS-CoV-2 Infection; Coronavirus Disease 2019 (COVID-19)
Interventions
SARS-CoV-2 mRNA Vaccine (CVnCoV); Quadrivalent influenza vaccine (QIV); Placebo
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.